TPG sells Par Pharmaceutical to Endo for $8bn
- Generic Drugs
- Controlled Release
- Full Acquisition
- Payment Includes Cash
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.